Overview

Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the effects of MOA-728 on cardiac repolarization in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Bausch Health Americas, Inc.
Valeant Pharmaceuticals International, Inc.